About the Authors
- Jifeng Zhang
-
Affiliation Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
- Changyong Xue
-
Affiliation Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
- Tianqing Zhu
-
Affiliation Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
- Anuradha Vivekanandan
-
Affiliation Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
- Subramaniam Pennathur
-
Affiliation Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
- Zhongmin Alex Ma
-
Affiliation Diapin Therapeutics Limited Liability Company, Ann Arbor, Michigan, United States of America
- Y. Eugene Chen
-
* E-mail: echunum@umich.edu
Affiliation Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America
Competing Interests
Dr. Ma is an employee and Dr. Chen is a major partner in Diapin Therapeutics LLC, a company developing Diapin to treat T2D. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: YEC. Performed the experiments: JZ CX TZ. Analyzed the data: JZ CX TZ. Contributed reagents/materials/analysis tools: AV SP. Wrote the paper: ZAM.